{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910254544303321"]
[null,null,"Titolo",null,"Breast Disease : Management and Therapies / / edited by Adnan Aydiner, Abdullah İgci, Atilla Soran"]
[null,null,"Pubbl/distr/stampa",null,"Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016"]
[null,null,"ISBN",null,"3-319-26012-X"]
[null,null,"Edizione",null,"[1st ed. 2016.]"]
[null,null,"Descrizione fisica",null,"1 online resource (922 p.)"]
[null,null,"Disciplina",null,"610"]
[null,null,"Soggetti",null,"Oncology"]
[{"$nulls":4},"Cancer - Treatment"]
[{"$nulls":4},"Radiology"]
[{"$nulls":4},"Cancer Therapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"Section I Invasive Breast Cancer Biopsy Techniques in non-Palpable or Palpable Breast Lesions -- Evaluation of Patients for Metastases Prior To Primary Therapy -- Staging of Breast Cancer -- Surgical Treatment of Early-Stage Breast Cancer -- Evaluation of Axillary Nodes -- Breast Reconstruction -- Adjuvant Systemic Therapy: Endocrine Therapy -- Adjuvant Systemic Chemotherapy for HER2-Negative Disease -- Adjuvant Therapy for Her-2/neu positive Early Breast Cancer -- Post-Mastectomy Adjuvant Radiotherapy (PMRT) -- Adjuvant Radiation Therapy after Preoperative Chemotherapy -- Breast-Conserving Therapy: Hypofractionated and Conventional Whole-Breast Irradiation and Accelerated Partial-Breast Irradiation -- Section II Preoperative systemic therapy Preoperative Therapy for Operable Breast Cancer -- Neoadjuvant Hormonal Therapy in Breast Cancer -- Systemic Therapy for Locally Advanced Breast Cancer -- Systemic Therapy for Inflammatory Breast Cancer -- <Section III Surgical Management of Patient with preoperative systemic therapy Surgical Management of Operable Breast Cancer -- Surgical Management of Locally Advanced Breast Cancer -- Surgical Management of Inflammatory Breast Cancer -- Section IV Special Therapeutic Problems Occult Primary Breast Cancer with Axillary Metastases -- Breast Cancer in Older Women -- Breast Cancer in Young Women (Premenopausal Breast Cancer) -- Male Breast Cancer -- Breast Cancer in Pregnancy -- Paget’s Disease of the "]
[{"$nulls":4},"Breast -- Phyllodes Tumors of the Breast -- Nonepithelial Malignancies of the Breast -- Section V Evaluation after Primary Therapy and Management of Recurrent Breast Cancer Surveillance of Patients Following Primary Therapy -- Surgery for the Primary Tumor in Patients with De Novo Stage IV Breast Cancer -- Local-Regional Recurrence after Breast-Conservation Treatment or Mastectomy -- Treatment of Metastatic Breast Cancer: Endocrine Therapy -- Treatment of Metastatic Breast Cancer: Chemotherapy -- Treatment of HER2-Overexpressing Metastatic Breast Cancer -- End-of-Life Considerations in Patients with Breast Cancer Section VI New Breast Cancer Therapeutic Approaches Angiogenesis Inhibition in Breast Cancer -- Tyrosine Kinase Inhibitors Section VII Site-Specific Therapy of Metastatic Breast Cancer Neurological Metastases -- Ocular Metastases -- Management of Malignant Pleural Effusions in Breast Cancer -- Management of Discrete Pulmonary Nodules -- Management of Isolated Liver Metastasis -- Bone-directed Therapy and Breast Cancer: Bisphosphonates, Monoclonal Antibodies, and Radionuclides -- The Local Management of Bone Metastases -- Section VIII Review of the breast cancer management A Review of Local and Systemic Therapy in Breast Cancer -- Decision Pathways in Breast Cancer Management -- Section IX Supportive Carein Breast Cancer Nursing Care and Management -- Psychosocial Adaptation During and After Breast Cancer -- Breast Cancer-Related Lymphedema (BCRL) -- Reproductive Issues in Breast Cancer -- Onco-Cardiology for Breast Cancer."]
[null,null,null,"Sommario/riassunto","This second volume of the handbook on breast disease provides a comprehensive overview of its clinical management and current therapies. It brings readers up to speed with the latest guidelines and therapeutic regimens in breast cancer and provides and in-depth account of current and new therapeutic approaches. Divided in themed parts, the book examines invasive breast cancer, pre-operative systemic therapy surgical management and recurrence among others, thus providing an in-depth account of breast cancer at the clinical stage. Among the themed parts are a section dedicated to special therapeutic problems, such as breast cancer in older women, Paget’s disease and phyllodes tumors, and a section on supportive and follow-up care. By adopting a multidisciplinary approach to breast cancer, this book is a must- have for breast cancer practitioners. With a high number of colored illustrations and edited by highly experienced clinicians, this work enables readers to gain an interdisciplinary perspective on breast diseases. Contributions from an international team of experts present invaluable insight into clinical practice across different settings. Covering both theoretical and practical aspects of breast cancer, this is a highly informative and carefully presented book which will appeal to an international audience of medical, radiation and surgical oncologists."]